joining the dots of recent obj announcements, page-6

excellent post coppertop.

Another factor to consider imo is the current market situation. A lot of funds have been pulled from the overall market over the last few months. "The Experts" have incorrectly recommended to invest for the short term and look for a quick buck. Those that do not follow OBJ or this market segment treat a .022c stock with much reservation. The prevailing investment attitude is capital preservation.
Now when it comes to OBJ an absolutely compelling history of progress, my assessment is that as the deals with global partners (which are now imminent) are announced and start generating revenue the SP will be re rated in substantial licks.
I also noticed that over the last 12 months the Bio market segment is getting a lot more exposure not only in Aust but in other markets around the world. This is a market segment where a lot of money can be accumulated in a very short period. Mining/energy/industrials/financials are not a turn on at the moment, bio does have blue sky potential. The US economy seems to be settling down with very slow growth which will help to steady the market, Once the European mess gets some sorted with a course of action, the timing for OBJ's entrance onto centre stage will be perfect.

hoofa is brushed with optimism. OBJ has done the research, has the product, has the marketing partners, has the distribution channels, Is lean on staff, has the professionals where it matters, research and commercial negotiating. Has cash.

yep its all systems go.

With any luck and no announcements in the near future the SP may drift lower, giving me the opportunity to continue buying at these prices which in due course will never been seen again.

Good luck to all holders.